Sepsis and the muscle tissue. A narrative review

1. BORGES RC, CARVALHO CRF, COLOMBO AS, DA SILVA BORGES MP, SORIANO FG. Physical activity, muscle strength, and exercise capacity 3 months after severe sepsis and septic shock. Intensive Care Med. 2015;41(8):1433–1444.10.1007/s00134-015-3914-y26109398 Search in Google Scholar

2. CALLAHAN LA, SUPINSKI GS. Sepsis-induced myopathy. Crit Care Med. 2009;37(10 Suppl):S354-S367.10.1097/CCM.0b013e3181b6e439396751520046121 Search in Google Scholar

3. LATRONICO N, GOSSELINK R. A guided approach to diagnose severe muscle weakness in the intensive care unit. Rev Bras Ter intensiva. 2015;27(3):199–201.10.5935/0103-507X.20150036459211126376161 Search in Google Scholar

4. HERMANS G, VAN MECHELEN H, CLERCKX B, et al. Acute outcomes and 1-year mortality of intensive care unit-acquired weakness. A cohort study and propensity-matched analysis. Am J Respir Crit Care Med. 2014;190(4):410–420.10.1164/rccm.201312-2257OC24825371 Search in Google Scholar

5. SHEPHERD S, BATRA A, LERNER DP. Review of Critical Illness Myopathy and Neuropathy. The Neurohospitalist. 2017;7(1):41–48.10.1177/1941874416663279516709328042370 Search in Google Scholar

6. BOLTON CF, LAVERTY DA, BROWN JD, WITT NJ, HAHN AF, SIBBALD WJ. Critically ill polyneuropathy: electrophysiological studies and differentiation from Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry. 1986;49(5):563–573.10.1136/jnnp.49.5.56310288113011996 Search in Google Scholar

7. MACFARLANE IA, ROSENTHAL FD. Severe myopathy after status asthmaticus. Lancet (London, England). 1977;2(8038):615. Search in Google Scholar

8. De Jonghe B, Lacherade J-C, Sharshar T, Outin H. Intensive care unit-acquired weakness: risk factors and prevention. Crit Care Med. 2009;37(10 Suppl):S309–15.10.1097/CCM.0b013e3181b6e64c20046115 Search in Google Scholar

9. BOLTON CF. Neuromuscular manifestations of critical illness. Muscle Nerve. 2005;32(2):140–163.10.1002/mus.2030415825186 Search in Google Scholar

10. BIRD SJ. Diagnosis and management of critical illness polyneuropathy and critical illness myopathy. Curr Treat Options Neurol. 2007;9(2):85–92.10.1007/s11940-007-0034-117298769 Search in Google Scholar

11. WEBER-CARSTENS S, DEJA M, KOCH S, et al. Risk factors in critical illness myopathy during the early course of critical illness: a prospective observational study. Crit Care. 2010;14(3):R119.10.1186/cc9074291176720565863 Search in Google Scholar

12. FRIEDRICH O, REID MB, VAN DEN BERGHE G, et al. The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill. Physiol Rev. 2015;95(3):1025–1109.10.1152/physrev.00028.2014 Search in Google Scholar

13. QIU Y, JIANG L, XI X. [Early incidence and prognosis of ICU-acquired weakness in mechanical ventilation patients]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019;31(7):821–826. Search in Google Scholar

14. LATRONICO N, BOLTON CF. Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis. Lancet Neurol. 2011;10(10):931–941.10.1016/S1474-4422(11)70178-8 Search in Google Scholar

15. VANHOREBEEK I, LATRONICO N, VAN DEN BERGHE G. ICU-acquired weakness. Intensive Care Med. 2020;46(4):637–653.10.1007/s00134-020-05944-4 Search in Google Scholar

16. DAMIAN MS, WIJDICKS EFM. The clinical management of neuromuscular disorders in intensive care. Neuromuscul Disord. 2019;29(2):85–96.10.1016/j.nmd.2018.12.005 Search in Google Scholar

17. BOUGLÉ A, ROCHETEAU P, SHARSHAR T, CHRÉTIEN F. Muscle regeneration after sepsis. Crit Care. 2016;20(1):131.10.1186/s13054-016-1308-3 Search in Google Scholar

18. LANONE S, MEBAZAA A, HEYMES C, et al. Muscular contractile failure in septic patients: role of the inducible nitric oxide synthase pathway. Am J Respir Crit Care Med. 2000;162(6):2308–2315.10.1164/ajrccm.162.6.2001097 Search in Google Scholar

19. HOTCHKISS RS, STRASSER A, MCDUNN JE, SWANSON PE. Cell death. N Engl J Med. 2009;361(16):1570–1583.10.1056/NEJMra0901217 Search in Google Scholar

20. MAESTRAGGI Q, LEBAS B, CLERE-JEHL R, et al. Skeletal Muscle and Lymphocyte Mitochondrial Dysfunctions in Septic Shock Trigger ICU-Acquired Weakness and Sepsis-Induced Immunoparalysis. Biomed Res Int. 2017;2017:7897325.10.1155/2017/7897325 Search in Google Scholar

21. BREALEY D, BRAND M, HARGREAVES I, et al. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet (London, England). 2002;360(9328):219–223.10.1016/S0140-6736(02)09459-X Search in Google Scholar

22. PASCUAL-GUARDIA S, ÁRBOL F, SÁNCHEZ E, et al. [Inflammation and oxidative stress in respiratory and limb muscles of patients with severe sepsis]. Med Clin (Barc). 2013;141(5):194–200.10.1016/j.medcli.2012.05.02622841463 Search in Google Scholar

23. KLAUDE M, MORI M, TJÄDER I, GUSTAFSSON T, WERNERMAN J, ROOYACKERS O. Protein metabolism and gene expression in skeletal muscle of critically ill patients with sepsis. Clin Sci (Lond). Search in Google Scholar

24. LAGHI F, TOBIN MJ. Disorders of the respiratory muscles. Am J Respir Crit Care Med. 2003;168(1):10–48.10.1164/rccm.220602012826594 Search in Google Scholar

25. JAGOE RT, GOLDBERG AL. What do we really know about the ubiquitin-proteasome pathway in muscle atrophy? Curr Opin Clin Nutr Metab Care. 2001;4(3).10.1097/00075197-200105000-0000311517350 Search in Google Scholar

26. VAN HEES HWH, SCHELLEKENS W-JM, LINKELS M, et al. Plasma from septic shock patients induces loss of muscle protein. Crit Care. 2011;15(5):R233–R233.10.1186/cc10475333478121958504 Search in Google Scholar

27. FRIEDRICH O. Critical illness myopathy: sepsis-mediated failure of the peripheral nervous system. Eur J Anaesthesiol | EJA. 2008;25.10.1017/S026502150700326218289421 Search in Google Scholar

28. LACOMIS D. Neuromuscular disorders in critically ill patients: review and update. J Clin Neuromuscul Dis. 2011;12(4):197–218.10.1097/CND.0b013e3181b5e14d22361518 Search in Google Scholar

29. PATERNOSTRO-SLUGA T, GRIM-STIEGER M, POSCH M, et al. Reliability and validity of the Medical Research Council (MRC) scale and a modified scale for testing muscle strength in patients with radial palsy. J Rehabil Med. 2008;40(8):665–671.10.2340/16501977-023519020701 Search in Google Scholar

30. ALI NA, O’BRIEN JMJ, HOFFMANN SP, et al. Acquired weakness, handgrip strength, and mortality in critically ill patients. Am J Respir Crit Care Med. 2008;178(3):261–268.10.1164/rccm.200712-1829OC18511703 Search in Google Scholar

31. LATRONICO N, NATTINO G, GUARNERI B, et al. Validation of the peroneal nerve test to diagnose critical illness polyneuropathy and myopathy in the intensive care unit: the multicentre Italian CRIMYNE-2 diagnostic accuracy study. F1000Research. 2014;3:127.10.12688/f1000research.3933.1 Search in Google Scholar

32. KHAN J, HARRISON TB, RICH MM, MOSS M. Early development of critical illness myopathy and neuropathy in patients with severe sepsis. Neurology. 2006;67(8):1421–1425.10.1212/01.wnl.0000239826.63523.8e17060568 Search in Google Scholar

33. LEFAUCHEUR J-P, NORDINE T, RODRIGUEZ P, BROCHARD L. Origin of ICU acquired paresis determined by direct muscle stimulation. J Neurol Neurosurg Psychiatry. 2006;77(4):500–506.10.1136/jnnp.2005.070813207751716306155 Search in Google Scholar

34. Z’GRAGGEN WJ, BRANDER L, TUCHSCHERER D, SCHEIDEGGER O, TAKALA J, BOSTOCK H. Muscle membrane dysfunction in critical illness myopathy assessed by velocity recovery cycles. Clin Neurophysiol Off J Int Fed Clin Neurophysiol. 2011;122(4):834–841.10.1016/j.clinph.2010.09.02421044861 Search in Google Scholar

35. CRONE C. Tetraparetic critically ill patients show electrophysiological signs of myopathy. Muscle Nerve. 2017;56(3):433–440.10.1002/mus.2552527997678 Search in Google Scholar

36. RAGHIG H, BRYAN YOUNG G, HAMMOND R, NICOLLE M. A Comparison of EMG and Muscle Biopsy in ICU Weakness. Neurocrit Care. 2010;13(3):326–330.10.1007/s12028-010-9431-520717748 Search in Google Scholar

37. LARSSON L, LI X, EDSTRÖM L, et al. Acute quadriplegia and loss of muscle myosin in patients treated with nondepolarizing neuromuscular blocking agents and corticosteroids: mechanisms at the cellular and molecular levels. Crit Care Med. 2000;28(1):34–45.10.1097/00003246-200001000-0000610667496 Search in Google Scholar

38. KERBAUL F, BROUSSE M, COLLART F, et al. Combination of histopathological and electromyographic patterns can help to evaluate functional outcome of critical ill patients with neuromuscular weakness syndromes. Crit Care. 2004;8(6):R358–R366.10.1186/cc2925106504915566579 Search in Google Scholar

39. HADDA V, KUMAR R, KHILNANI GC, et al. Trends of loss of peripheral muscle thickness on ultrasonography and its relationship with outcomes among patients with sepsis. J intensive care. 2018;6:81.10.1186/s40560-018-0350-4629201330564367 Search in Google Scholar

40. BORGES RC, SORIANO FG. Association Between Muscle Wasting and Muscle Strength in Patients Who Developed Severe Sepsis and Septic Shock. Shock. 2019;51(3):312–320.10.1097/SHK.000000000000118329757913 Search in Google Scholar

41. PUTHUCHEARY ZA, RAWAL J, MCPHAIL M, et al. Acute Skeletal Muscle Wasting in Critical Illness. JAMA. 2013;310(15):1591–1600.10.1001/jama.2013.27848124108501 Search in Google Scholar

42. GRIMM A, TESCHNER U, PORZELIUS C, et al. Muscle ultrasound for early assessment of critical illness neuromyopathy in severe sepsis. Crit Care. 2013;17(5):R227–R227.10.1186/cc13050405741324499688 Search in Google Scholar

43. PUTHUCHEARY ZA, PHADKE R, RAWAL J, et al. Qualitative Ultrasound in Acute Critical Illness Muscle Wasting. Crit Care Med. 2015;43(8):1603–1611.10.1097/CCM.000000000000101625882765 Search in Google Scholar

44. DEMOULE A, JUNG B, PRODANOVIC H, et al. Diaphragm dysfunction on admission to the intensive care unit. Prevalence, risk factors, and prognostic impact-a prospective study. Am J Respir Crit Care Med. 2013;188(2):213–219.10.1164/rccm.201209-1668OC23641946 Search in Google Scholar

45. SCHREIBER A, BERTONI M, GOLIGHER EC. Avoiding Respiratory and Peripheral Muscle Injury During Mechanical Ventilation: Diaphragm-Protective Ventilation and Early Mobilization. Crit Care Clin. 2018;34(3):357–381.10.1016/j.ccc.2018.03.00529907270 Search in Google Scholar

46. PETROF BJ. Diaphragmatic dysfunction in the intensive care unit: caught in the cross-fire between sepsis and mechanical ventilation. Crit Care. 2013;17(4):R181–R181.10.1186/cc12864405599923981865 Search in Google Scholar

47. LU Z, GE H, XU L, GUO F, ZHANG G, WU Y. Alterations in diaphragmatic function assessed by ultrasonography in mechanically ventilated patients with sepsis. J Clin Ultrasound. 2019;47(4):206–211.10.1002/jcu.2269030671990 Search in Google Scholar

48. LU ZH, GUO F, ZHANG G, GE HQ, XU LL, CHEN YL. [A clinical study of diaphragmatic dysfunction in subjects with mechanical ventilation in sepsis]. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese J Tuberc Respir Dis. 2018;41(9):696–700. Search in Google Scholar

49. JUNG B, NOUGARET S, CONSEIL M, et al. Sepsis Is Associated with a Preferential Diaphragmatic Atrophy: A Critically Ill Patient Study Using Tridimensional Computed Tomography. Anesthesiology. 2014;120(5):1182–1191.10.1097/ALN.000000000000020124608360 Search in Google Scholar

50. BALDWIN CE, BERSTEN AD. Alterations in Respiratory and Limb Muscle Strength and Size in Patients With Sepsis Who Are Mechanically Ventilated. Phys Ther. 2014;94(1):68–82.10.2522/ptj.2013004824009347 Search in Google Scholar

51. VIVIER E, ROUSSEY A, DOROSZEWSKI F, et al. Atrophy of Diaphragm and Pectoral Muscles in Critically Ill Patients. Anesthesiology. 2019;131(3):569–579.10.1097/ALN.000000000000273731094757 Search in Google Scholar

52. GOLIGHER EC, DRES M, FAN E, et al. Mechanical Ventilation-induced Diaphragm Atrophy Strongly Impacts Clinical Outcomes. Am J Respir Crit Care Med. 2018;197(2):204–213.10.1164/rccm.201703-0536OC28930478 Search in Google Scholar